Linked Life Data

15683111

Source:http://linkedlifedata.com/resource/pubmed/id/15683111

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2005-2-1
pubmed:abstractText
A recent study has shown that triple anti-platelet therapy (cilostazol+clopidogrel+aspirin) resulted in a significantly lower restenosis rate after coronary stenting than did conventional therapy (clopidogrel+aspirin). However, the anti-platelet effects of cilostazol, when combined with clopidogrel and aspirin, have not been evaluated.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1226-3303
pubmed:author
pubmed:issnType
Print
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
230-6
pubmed:dateRevised
2006-9-26
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Effects of cilostazol on platelet activation in coronary stenting patients who already treated with aspirin and clopidogrel.
pubmed:affiliation
Department of Internal Medicine, Ansan Hospital, Korea University College of Medicine, Seoul, Korea.
pubmed:publicationType
Journal Article